693
Views
0
CrossRef citations to date
0
Altmetric
Brief Communication

A novel strategy for orthogonal genetic regulation on different RNA targeted loci simultaneously

, , , , , , , , & ORCID Icon show all
Pages 1172-1178 | Received 14 Apr 2022, Accepted 24 Oct 2022, Published online: 09 Nov 2022

References

  • Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002;296(5567):550–553.
  • Vickers TA, Crooke ST. The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA. Nucleic Acids Res. 2015;43(18):8955–8963.
  • Konermann S, Lotfy P, Brideau NJ, et al. Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors. Cell. 2018;173(3):665–76 e14.
  • Abudayyeh OO, Gootenberg JS, Essletzbichler P, et al. RNA targeting with CRISPR-Cas13. Nature. 2017;550(7675):280–284.
  • Wilson C, Chen PJ, Miao Z, et al. Programmable m(6)A modification of cellular RNAs with a Cas13-directed methyltransferase. Nat Biotechnol. 2020;38(12):1431–1440.
  • Abudayyeh OO, Gootenberg JS, Franklin B, et al. A cytosine deaminase for programmable single-base RNA editing. Science. 2019;365(6451):382–386.
  • Cubillos-Ruiz JR, Baird JR, Tesone AJ, et al. Reprogramming Tumor-Associated Dendritic Cells In Vivo Using miRNA Mimetics Triggers Protective Immunity against Ovarian Cancer. Cancer Res. 2012;72(7):1683–1693.
  • Ji C, Guo X. The clinical potential of circulating microRNAs in obesity. Nat Rev Endocrinol. 2019;15(12):731–743.
  • Hosfield DJ, Frank G, Weng Y, et al. Newly discovered archaebacterial flap endonucleases show a structure-specific mechanism for DNA substrate binding and catalysis resembling human flap endonuclease-1. J Biol Chem. 1998;273(42):27154–27161.
  • Chapados BR, Hosfield DJ, Han S, et al. Structural basis for FEN-1 substrate specificity and PCNA-mediated activation in DNA replication and repair. Cell. 2004;116(1):39–50.
  • Harrington JJ, Lieber MR. The characterization of a mammalian DNA structure-specific endonuclease. EMBO J. 1994;13(5):1235–1246.
  • Brodersen P, Voinnet O. Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol. 2009;10(2):141–148.
  • Schwarz DS, Hutvagner G, Du T, et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell. 2003;115(2):199–208.
  • Damodaran M, Chinambedu Dandapani M, SimonDuraiRaj S, et al. Differentially expressed miR-20, miR-21, miR-100, miR-125a and miR-146a as a potential biomarker for prostate cancer. Mol Biol Rep. 2021;48(4):3349–3356.
  • Barker A, Giles KM, Epis MR, et al. Regulation of ErbB receptor signalling in cancer cells by microRNA. Curr Opin Pharmacol. 2010;10(6):655–661.
  • Xu N, Papagiannakopoulos T, Pan G, et al. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell. 2009;137(4):647–658.
  • Kao H-I, Henricksen LA, Liu Y, et al. Cleavage specificity of Saccharomyces cerevisiae flap endonuclease 1 suggests a double-flap structure as the cellular substrate. J Biol Chem. 2002;277(17):14379–14389.
  • Tian K, Guo Y, Zou B, et al. DNA and RNA editing without sequence limitation using the flap endonuclease 1 guided by hairpin DNA probes. Nucleic Acids Res. 2020;48(20):e117.
  • Vaschetto LM. miRNA activation is an endogenous gene expression pathway. RNA Biol. 2018;15(6):826–828.